Cutspas-DM

Brand Name : Cutspas-DM

Packing : 10*10

Composition : Drotaverine 80mg + Mefenamic Acid 250mg Tablet

 

Cutspas-DM by Norchem Healthcare: Fast Relief from Abdominal Pain, Cramps, and Spasms

Abdominal discomfort, cramps, and painful spasms are common symptoms in conditions like irritable bowel syndrome (IBS), menstrual cramps, gastroenteritis, and urinary tract infections. These symptoms, while often not life-threatening, can severely impact a patient’s daily life, productivity, and emotional well-being. To provide quick and effective relief, Norchem Healthcare introduces Cutspas-DM, a powerful antispasmodic and analgesic combination therapy.

Cutspas-DM combines Drotaverine Hydrochloride and Mefenamic Acid, two well-established drugs known for their potent action in relieving smooth muscle spasms and inflammation-induced pain. Trusted by doctors and preferred by patients, Cutspas-DM stands out as a safe, effective, and fast-acting medication in the segment of gastrointestinal and gynecological care.

Composition of Cutspas-DM

Each film-coated tablet of Cutspas-DM contains:

  • Drotaverine Hydrochloride IP – 80 mg
     
  • Mefenamic Acid IP – 250 mg
     

This combination offers dual-action therapy—relaxing smooth muscles while simultaneously reducing inflammation and pain, making it ideal for a wide range of painful abdominal and muscular conditions.

How It Helps?

1. Drotaverine Hydrochloride (80 mg) – The Antispasmodic

Drotaverine is a selective phosphodiesterase-4 inhibitor that:

  • Increases intracellular levels of cAMP and cGMP, leading to smooth muscle relaxation.
     
  • Relieves spasm of involuntary muscles of the gastrointestinal tract, urinary tract, and uterus.
     
  • Does not affect the autonomic nervous system, hence it avoids side effects like dry mouth or drowsiness seen with other antispasmodics.
     

2. Mefenamic Acid (250 mg) – The Anti-inflammatory Analgesic

Mefenamic Acid is a non-steroidal anti-inflammatory drug (NSAID) that:

  • Inhibits cyclooxygenase (COX-1 and COX-2) enzymes responsible for the formation of prostaglandins.
     
  • Reduces pain, inflammation, and fever effectively.
     
  • Especially beneficial in dysmenorrhea, colicky abdominal pain, and muscle aches.
     

Together, these two agents in Cutspas-DM provide powerful, fast-acting relief from spasmodic pain and inflammation.

Medical Conditions Treated

Cutspas-DM is indicated for the symptomatic treatment of:

  • Irritable Bowel Syndrome (IBS)
     
  • Renal colic
     
  • Biliary colic
     
  • Menstrual cramps (primary dysmenorrhea)
     
  • Gastrointestinal colic
     
  • Urinary tract spasm and pain
     
  • Post-operative abdominal pain
     
  • Inflammatory pelvic disease
     
  • Muscle cramps associated with inflammation
     

Its broad-spectrum action makes it an essential choice in gynecology, gastroenterology, urology, and general practice.

Key Features of Cutspas-DM

 Dual-Action Formula
Targets both the root cause of spasms and associated inflammation and pain.

 Rapid Onset of Action
Provides fast relief from colicky and crampy pain, improving patient comfort quickly.

 Non-Sedative Antispasmodic
Drotaverine does not cross the blood-brain barrier significantly, hence no drowsiness or CNS depression.

 Safe for Gynecological Use
Highly effective in treating menstrual pain without hormonal side effects.

Wide Range of Indications
Suitable for gastrointestinal, urinary, and gynecological pain management.

Dosage and Administration

Adults: 1 tablet 2 to 3 times daily or as prescribed by the physician.
 

  • Route: Oral, with or after meals to minimize gastric irritation.
     
  • Duration: Typically used for short-term relief of spasmodic pain; prolonged use should be under medical supervision.

Precautions and Contraindications

Precautions

  • Use cautiously in patients with renal, hepatic, or cardiac impairment.
     
  • Not recommended for patients with active peptic ulcers.
     
  • Avoid alcohol consumption during treatment to reduce the risk of gastrointestinal bleeding.
     
  • Elderly patients may be more susceptible to NSAID-related side effects.

Contraindications

  • Hypersensitivity to Drotaverine, Mefenamic Acid, or any other component of the formulation.
     
  • Patients with history of gastrointestinal bleeding, ulceration, or NSAID-induced asthma.
     
  • Not to be used in pregnant or breastfeeding women unless prescribed by a doctor.

Side Effects

Cutspas-DM is generally well-tolerated. However, some patients may experience:

  • Nausea or vomiting
     
  • Abdominal discomfort or bloating
     
  • Allergic skin reactions like rashes
     
  • Headache or dizziness
     
  • Rarely, gastrointestinal bleeding (with prolonged NSAID use)
     

In case of severe side effects, patients should discontinue the medicine and seek immediate medical advice.

Cutspas-DM vs. Other Antispasmodics

Parameter

Cutspas-DM

Conventional Antispasmodics

Action

Spasm + Inflammation

Spasm only

Sedation

No

Often sedative

Gynecological Use

Highly effective

Limited

Speed of Relief

Fast onset

Variable

Additional Pain Control

Yes (Mefenamic Acid)

No

This comparison shows why Cutspas-DM is the preferred choice for doctors aiming for quick, comprehensive, and patient-friendly therapy.

 

 

Norchem Healthcare: Commitment to Quality

Norchem Healthcare has carved a niche in the Indian pharmaceutical sector as a trusted name for innovative, affordable, and reliable formulations. With state-of-the-art manufacturing facilities and rigorous quality checks, Norchem ensures that every tablet of Cutspas-DM delivers consistent therapeutic results.

Norchem is WHO-GMP certified and works with a network of PCD franchise partners across India, making its quality medicines accessible in even the remotest parts of the country.

Market Demand and Opportunity

Pain and spasmodic conditions are among the most frequent complaints in outpatient clinics. According to a national pharmaceutical survey:

  • Over 30% of prescriptions in OPD settings involve pain management medications.
     
  • Antispasmodic + NSAID combinations are highly preferred due to their dual-action relief.
     
  • The demand for effective, safe antispasmodics is growing rapidly, especially in women's health and GI segments.
     

Cutspas-DM presents a high-demand, high-prescription potential for Norchem Healthcare and its distributors.

Conclusion

Cutspas-DM by Norchem Healthcare is a clinically trusted, patient-friendly, and effective solution for painful spasmodic conditions. By combining the muscle-relaxing power of Drotaverine with the anti-inflammatory effect of Mefenamic Acid, Cutspas-DM provides rapid and long-lasting relief across multiple indications.

Whether it's menstrual cramps, abdominal colic, or GI spasms, Cutspas-DM is the go-to therapy for doctors seeking fast relief without sedation.

Relief from pain isn’t a luxury—it’s a necessity. With Cutspas-DM, patients can live, work, and move without the burden of spasmodic pain.



 
Cutspas-DM